Target intelligence / Profile preview

F-type proton-transporting ATPase of Streptococcus mutans (F-ATPase)

Target
F-ATPase
Molecular classification
Enzyme, Transporter (specifically, a membrane-bound proton pump of the ATPase family), F-type ATPase family
01

Overview

The F-type proton-transporting ATPase of *Streptococcus mutans* (F-ATPase) is a multi-subunit, membrane-bound enzyme complex responsible for extruding protons (H⁺) from the cytoplasm in exchange for hydrolyzing ATP. This process maintains a neutral to slightly basic intracellular pH despite the highly acidic environment created by carbohydrate fermentation in dental plaque, thus enabling S. mutans to survive, metabolize, and outcompete less acid-tolerant oral bacteria. The F-ATPase is upregulated in response to environmental acidification (optimal activity at pH 6.0), and its gene cluster and structure are highly conserved with F-ATPases from other bacteria but show specific regulatory adaptations in S. mutans. Activity of this enzyme is critical for the aciduric (acid-tolerant) phenotype that underlies S. mutans virulence in dental caries and is a validated therapeutic target for novel antibacterial agents against tooth decay. Several plant-derived compounds, such as curcumin and piceatannol, have been shown to inhibit S. mutans F-ATPase and suppress bacterial survival under acid stress. Selectivity for the bacterial enzyme over mammalian homologs is a key consideration in drug development targeting this enzyme.

Other names
F1F0-ATPaseF0F1-ATPaseH+-translocating ATPaseproton-pumping ATPase
02

Mechanism of action

Inhibitors block ATP hydrolysis activity and proton translocation, disrupting intracellular pH homeostasis, reducing S. mutans growth and survival in acidic environments.

03

Biological functions

Maintenance of intracellular pH (proton extrusion)Acid toleranceVirulence factor in caries formationEnergy production via ATP hydrolysis/coupling to proton translocation
04

Disease associations

Infection (notably, in dental caries/cavities pathogenesis)
05

Safety considerations

Therapeutic agents targeting bacterial F-ATPase could potentially cross-react with mammalian F-type ATPases due to high homology of ATP synthase catalytic subunits.Inhibition of the enzyme in non-cariogenic oral flora or human mitochondria is a potential off-target risk, underlining the need for target selectivity.
06

Interacting drugs

Curcumin

2 more in the full profile.

07

Biomarkers

atpD mRNA (β-subunit expression as a readout of F-ATPase induction)F-ATPase activity levels (functional readout for acid tolerance)

Beyond the preview

Go deeper on F-type proton-transporting ATPase of Streptococcus mutans (F-ATPase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on F-type proton-transporting ATPase of Streptococcus mutans (F-ATPase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call